Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Editorial.
Merseburger AS, Kübler H. Merseburger AS, et al. Aktuelle Urol. 2023 Sep;54(5):334. doi: 10.1055/a-2059-0520. Epub 2023 Aug 23. Aktuelle Urol. 2023. PMID: 37611591 German. No abstract available.
[Are there any volume-related effects on treatment options for patients with penile cancer? Results of a survey among university hospitals in Germany and Austria].
Lebentrau S, Yakac A, Lusuardi L, Thomas C, Sarcan S, Burger M, Merseburger AS, Wiegland J, Gilfrich C, Wolff I, May M. Lebentrau S, et al. Among authors: merseburger as. Aktuelle Urol. 2023 Aug;54(4):285-291. doi: 10.1055/a-2090-5199. Epub 2023 Jun 20. Aktuelle Urol. 2023. PMID: 37339667 German.
Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
Boddu VK, Zamzow P, Kramer MW, Merseburger AS, Gorantla SP, Klinger M, Cramer L, Sauer T, Gemoll T, von Bubnoff N, Gieseler F, Darabi M. Boddu VK, et al. Among authors: merseburger as. Cell Commun Signal. 2024 Feb 15;22(1):129. doi: 10.1186/s12964-024-01508-x. Cell Commun Signal. 2024. PMID: 38360687 Free PMC article.
Apalutamide plus androgen deprivation therapy in clinical subgroups of patients with metastatic castration-sensitive prostate cancer: A subgroup analysis of the randomised clinical TITAN study.
Merseburger AS, Agarwal N, Bhaumik A, Lefresne F, Karsh LI, Pereira de Santana Gomes AJ, Soto ÁJ, Given RW, Brookman-May SD, Mundle SD, McCarthy SA, Uemura H, Chowdhury S, Chi KN, Bjartell A. Merseburger AS, et al. Eur J Cancer. 2023 Nov;193:113290. doi: 10.1016/j.ejca.2023.113290. Epub 2023 Aug 11. Eur J Cancer. 2023. PMID: 37708629 Free article.
Mass Spectrometry-Based Biomarkers to Detect Prostate Cancer: A Multicentric Study Based on Non-Invasive Urine Collection without Prior Digital Rectal Examination.
Frantzi M, Culig Z, Heidegger I, Mokou M, Latosinska A, Roesch MC, Merseburger AS, Makridakis M, Vlahou A, Blanca-Pedregosa A, Carrasco-Valiente J, Mischak H, Gomez-Gomez E. Frantzi M, et al. Among authors: merseburger as. Cancers (Basel). 2023 Feb 11;15(4):1166. doi: 10.3390/cancers15041166. Cancers (Basel). 2023. PMID: 36831508 Free PMC article.
371 results